Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 randomized double-blind active-controlled study of remifentanil for analgesia in mechanically ventilated ICU patients
CTR20254333Phase 3Active
- Sponsor
- China National Pharmaceutical Industry Corp
- Start
- Jan 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of remifentanil in pain, sponsored by China National Pharmaceutical Industry Corp. Started Jan 2026; status: active.
02
Drugs
remifentanil
03
Conditions
pain
Beyond the preview
Go deeper on CTR20254333.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20254333.